Socioeconomic factors, medication subsidisation and the use of preventativecardiovascular disease medications in Australia.

dc.contributor.authorPaige, Ellie
dc.contributor.authorBanks, Emily
dc.contributor.authorAgostino, Jason
dc.contributor.authorBrieger, David
dc.contributor.authorPage, Karen
dc.contributor.authorJoshy, Grace
dc.contributor.authorBarrett, Eden
dc.contributor.authorKorda, Rosemary
dc.date.accessioned2025-04-24T02:02:29Z
dc.date.available2025-04-24T02:02:29Z
dc.date.issued2022
dc.date.updated2023-12-10T07:17:10Z
dc.description.abstractObjectives Cardiovascular disease (CVD) events are highly preventable through appropriate treatment and disproportionally affect socioeconomically disadvantaged individuals. This study quantified the relationship of socioeconomic factors to dispensing and persistent use of lipid- and blood pressure-lowering medication following hospital admission for a major CVD event (myocardial infarction, ischaemic stroke/transient ischaemic attack). Approach Data from 8,285 people with major CVD events aged ≥45 years from the Australian 45 and Up Study with linked medication dispensing data were used. Modified Poisson regression was used to estimate relative risks (RRs) for combined lipid- and blood pressure-lowering dispensing at three-months following hospital discharge and for 12-month persistent use, in relation to education, income, and level of medication subsidisation. Results Overall, 56% were dispensed guideline-recommended medications at three months and 37% persistently used them across 12 months. After adjusting for demographic factors, type of CVD and history of CVD hospitalisation, RRs for lowest (no educational qualifications) compared to highest education level (university degree) were 1.14 (95% CI: 1.06, 1.22) for medication dispensing and 1.15 (1.02, 1.29) for persistent medication use; 1.14 (1.06, 1.22) and 1.17 (1.04, 1.32) respectively for lowest (<$20,000) versus highest (≥$70,000) household pre-tax income; and 1.25 (1.17, 1.33) and 1.28 (1.15, 1.43) respectively for those receiving highest versus lowest subsidisation. There was little to no evidence of a relationship of income and education to medication use after adjustment for medication subsidisation. Conclusions While preventive medication use is sub-optimal, subsidisation is substantially associated with increased use and accounts for most of the relationship with socioeconomic position, suggesting medication subsidy schemes are working in the intended direction
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn2399-4908
dc.identifier.urihttps://hdl.handle.net/1885/733748626
dc.language.isoen_AUen_AU
dc.provenanceOpen Access under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/deed.en)
dc.publisherSwansea University, UK
dc.rights©2022 The authors
dc.rights.licenseCreative Commons Attribution licence
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/deed.en
dc.sourceInternational Journal of Population Data Science
dc.titleSocioeconomic factors, medication subsidisation and the use of preventativecardiovascular disease medications in Australia.
dc.typeJournal article
dcterms.accessRightsOpen Access
local.bibliographicCitation.issue3
local.bibliographicCitation.startpage207
local.contributor.affiliationPaige, Ellie, College of Health and Medicine, ANU
local.contributor.affiliationBanks, Emily, College of Health and Medicine, ANU
local.contributor.affiliationAgostino, Jason, College of Health and Medicine, ANU
local.contributor.affiliationBrieger, David, Concord Repatriation General Hospital
local.contributor.affiliationPage, Karen, Deakin University
local.contributor.affiliationJoshy, Grace, College of Health and Medicine, ANU
local.contributor.affiliationBarrett, Eden, College of Health and Medicine, ANU
local.contributor.affiliationKorda, Rosemary, College of Health and Medicine, ANU
local.contributor.authoruidPaige, Ellie, u4966053
local.contributor.authoruidBanks, Emily, u4106314
local.contributor.authoruidAgostino, Jason, u5150077
local.contributor.authoruidJoshy, Grace, u5029881
local.contributor.authoruidBarrett, Eden, u1098072
local.contributor.authoruidKorda, Rosemary, u4013381
local.description.notesImported from ARIES
local.identifier.absfor420605 - Preventative health care
local.identifier.ariespublicationU4615567xPUB9
local.identifier.citationvolume7
local.identifier.doi10.23889/ijpds.v7i3.1982
local.publisher.urlhttps://ijpds.org/
local.type.statusPublished Version
publicationvolume.volumeNumber7

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ipdln-2022-207.pdf
Size:
212.08 KB
Format:
Adobe Portable Document Format